Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Buy Genworth Financial Inc (GNW)

Page 1 of 2

Genworth Financial Inc (NYSE:GNW) was in 39 hedge funds’ portfolio at the end of March. GNW has experienced an increase in support from the world’s most elite money managers in recent months. There were 38 hedge funds in our database with GNW positions at the end of the previous quarter.

In today’s marketplace, there are tons of methods market participants can use to analyze stocks. A pair of the best are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top investment managers can trounce the S&P 500 by a solid margin (see just how much).

Genworth Financial Inc (NYSE:GNW)Equally as key, bullish insider trading activity is a second way to parse down the financial markets. As the old adage goes: there are plenty of motivations for an executive to cut shares of his or her company, but only one, very obvious reason why they would buy. Various empirical studies have demonstrated the market-beating potential of this strategy if shareholders understand what to do (learn more here).

Now, let’s take a look at the latest action encompassing Genworth Financial Inc (NYSE:GNW).

What does the smart money think about Genworth Financial Inc (NYSE:GNW)?

In preparation for this quarter, a total of 39 of the hedge funds we track were long in this stock, a change of 3% from the first quarter. With the smart money’s sentiment swirling, there exists a few noteworthy hedge fund managers who were increasing their holdings substantially.

According to our comprehensive database, Jonathon Jacobson’s Highfields Capital Management had the biggest position in Genworth Financial Inc (NYSE:GNW), worth close to $131.7 million, comprising 1.2% of its total 13F portfolio. Coming in second is John Paulson of Paulson & Co, with a $90 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Some other hedge funds that are bullish include Edward Lampert’s ESL Investments, Bill Miller’s Legg Mason Capital Management and Jim Simons’s Renaissance Technologies.

As industrywide interest jumped, key money managers have jumped into Genworth Financial Inc (NYSE:GNW) headfirst. ZWEIG DIMENNA PARTNERS, managed by Joe DiMenna, assembled the biggest position in Genworth Financial Inc (NYSE:GNW). ZWEIG DIMENNA PARTNERS had 22.2 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also initiated a $10.9 million position during the quarter. The other funds with new positions in the stock are Bruce Kovner’s Caxton Associates LP, John Murphy’s Alydar Capital, and Bruce Berkowitz’s Fairholme (FAIRX).

What do corporate executives and insiders think about Genworth Financial Inc (NYSE:GNW)?

Bullish insider trading is at its handiest when the company we’re looking at has seen transactions within the past half-year. Over the last 180-day time frame, Genworth Financial Inc (NYSE:GNW) has seen 1 unique insiders purchasing, and 1 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Genworth Financial Inc (NYSE:GNW). These stocks are Lincoln National Corporation (NYSE:LNC), Protective Life Corp. (NYSE:PL), Torchmark Corporation (NYSE:TMK), and Reinsurance Group of America Inc (NYSE:RGA). This group of stocks are the members of the life insurance industry and their market caps resemble GNW’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!